Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Steroid Pulse Therapy for Subclinical Borderline Changes in Renal Transplantation
NCT02664493Unknown
- Sponsor
- Samsung Medical Center
- Start
- Feb 2016
- Primary completion
- Jul 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of methylprednisolone in kidney transplant rejection (2 arms), sponsored by Samsung Medical Center. Primary endpoint: Reduction of acute rejection episode at 1 year. Status: unknown.
02
Drugs
methylprednisolone
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT02664493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02664493.